T-type Ca 2ϩ channels (TTCCs) are expressed in the developing heart, are not present in the adult ventricle, and are reexpressed in cardiac diseases involving cardiac dysfunction and premature, arrhythmogenic death. The goal of this study was to determine the functional role of increased Ca 2ϩ influx through reexpressed TTCCs in the adult heart. A mouse line with cardiac-specific, conditional expression of the ␣1G-TTCC was used to increase Ca 2ϩ influx through TTCCs. ␣1G hearts had mild increases in contractility but no cardiac histopathology or premature death. This contrasts with the pathological phenotype of a previously studied mouse with increased Ca 2ϩ influx through the L-type Ca 2ϩ channel (LTCC) secondary to overexpression of its ␤2a subunit. Although ␣1G and ␤2a myocytes had similar increases in Ca 2ϩ influx, ␣1G myocytes had smaller increases in contraction magnitude, and, unlike ␤2a myocytes, there were no increases in sarcoplasmic reticulum Ca 2ϩ loading. Ca 2ϩ influx through TTCCs also did not induce normal sarcoplasmic reticulum Ca 2ϩ release. ␣1G myocytes had changes in LTCC, SERCA2a, and phospholamban abundance, which appear to be adaptations that help maintain Ca 2ϩ homeostasis. Immunostaining suggested that the majority of ␣1G-TTCCs were on the surface membrane. Osmotic shock, which selectively eliminates T-tubules, induced a greater reduction in Lversus TTCC currents. These studies suggest that T-and LTCCs are in different portions of the sarcolemma (surface membrane versus T-tubules) and that Ca 2ϩ influx through these channels induce different effects on myocyte contractility and lead to distinct cardiac phenotypes.
C a 2ϩ influx through voltage-regulated ion channels is essential for initiating and regulating cardiac function. 1, 2 Changes in cytosolic [Ca 2ϩ ] also influence a variety of signaling pathways, 3, 4 regulate normal cardiac metabolism, 5 and cause both physiological and pathological hypertrophy. 6 -9 The primary pathway for Ca 2ϩ influx in the adult heart is via the L-type Ca 2ϩ channel (LTCC). This Ca 2ϩ influx pathway is essential for triggering sarcoplasmic reticulum (SR) Ca 2ϩ release and is the major source of Ca 2ϩ to load the SR. 10 Excess Ca 2ϩ influx through LTCCs has been linked to necrotic myocyte death, cardiac dysfunction, and premature death. 11 Ca 2ϩ can also enter cardiac myocytes through the voltageoperated T-type Ca 2ϩ channel (TTCC). These channels are expressed throughout cardiac development until the end of the fetal/neonatal period. [12] [13] [14] TTCC expression decreases soon after birth, with little or no expression in normal adult ventricular myocytes (VMs). TTCCs are reexpressed when the heart is subjected to pathological stressors that induce cardiac hypertrophy and failure [15] [16] [17] [18] [19] and are associated with depressed cardiac function and sudden death. 20 However, the functional significance of TTCC reexpression in adult VMs has not been established and is the focus of this study. Our major goal was to determine whether Ca 2ϩ influx through Tand L-type Ca 2ϩ channels induce different cardiac phenotypes.
Three TTCC genes have been identified, but only 2, Ca v 3.1 (␣1G) and Ca v 3.2 (␣1H), have been found in the heart. 12, 21, 22 All TTCCs have similar biophysical properties, including activation at more negative voltages and faster inactivation than LTCCs. Based on studies in Purkinje cells and guinea pig VMs, TTCC current (I Ca,T ) appears to be less efficient than LTCC current (I Ca,L ) in excitation-contraction (EC) coupling. 23, 24 Electrophysiological assessment of I Ca,T is technically difficult because of its small amplitude. Additionally, it is difficult to extrapolate findings in Purkinje cells to VMs because of the limited T-tubule and ryanodine receptor (RyR) organization of Purkinje cells. 25 ␣1G and ␣1H are reexpressed in the adult ventricle under pathological stress, [15] [16] [17] [18] [19] but the involvement of these channels in cardiac dysfunction, pathological remodeling and arrhythmias is not known. To understand the function of these channels in the myocardium, we generated mice with inducible, cardiac-specific expression of the ␣1G-TTCC. Increased Ca 2ϩ influx through TTCCs should augment myocyte contractility and activate Ca 2ϩ regulated signaling pathways. Recently, we showed that increasing Ca 2ϩ influx through LTCCs, by overexpressing its ␤2a subunit, increased myocyte contractility but eventually induced SR Ca 2ϩ overload and Ca 2ϩ -mediated myocyte necrosis, leading to heart failure and premature death. 11 In the present study, we asked whether excess Ca 2ϩ influx via TTCCs also causes alterations in contractility, cardiac dysfunction, and premature death.
Our experiments show that mice with cardiac-specific ␣1G-TTCC expression have increased Ca 2ϩ influx through functional TTCCs. Hearts from ␣1G animals were mildly hypercontractile, but there was no cardiac pathology or premature death. Myocytes isolated from ␣1G hearts had increased Ca 2ϩ influx, contractions, and systolic [Ca 2ϩ ] i transients, but the SR Ca 2ϩ load was not increased. The duration of the [Ca 2ϩ ] i transient and contractions were shortened, secondary to what appears to be adaptive changes in Ca 2ϩ regulatory proteins. Experiments with electrophysiological and immunostaining approaches suggest that ␣1G-TTCCs are more highly concentrated in the surface membrane than in T-tubules and their associated junctional SR. These findings explain why I Ca,T is an inefficient trigger for SR Ca 2ϩ release and an inefficient source of Ca 2ϩ to load the SR. These studies also show that unlike LTCCs, Ca 2ϩ influx through TTCCs does not induce Ca 2ϩ -mediated cardiac pathologies or arrhythmogenic sudden death. Taken together, our new findings suggest that the source of the Ca 2ϩ influx pathway can be a critical determinant of the induced cardiac phenotype.
Materials and Methods
All experiments involving animals were approved by the Institutional Animal Care and Use Committee of Temple University.
Mice
Transgenic mice with conditional and cardiac-specific expression of mouse ␣1G subunit or rat ␤2a subunit were generated using a modified murine ␣-myosin heavy chain (␣-MHC) promoter expression vector. 11, 26 Animals between 10 to 16 weeks of age were used for experiments.
Echocardiography
Whole heart morphology and function were assessed via echocardiography. Hearts were viewed in short-axis and analyzed in M-mode.
Histology
Hearts from animals (9 months old) were fixed in formalin, and longitudinal sections were evaluated for gross morphology and fibrosis.
Figure 1.
Properties of mice with ␣1G-TTCC overexpression. A, Schematic of the bitransgenic system for cardiac-specific ␣1G overexpression. tTA is the tetracycline-controlled transactivator system. B, Histology of ␣1G mice was not different than control. C, Representative M-mode echo recording in control and ␣1G mice. D, Fractional shortening (FS) and ejection fraction (EF) were greater in ␣1G vs control mice at comparable heart rates. *PϽ0.05.
Western Blot Analysis
Abundance/phosphorylation status of Ca 2ϩ regulatory proteins in ventricular tissue was assessed as described previously. 27
Electrophysiology
[Ca 2ϩ ] i transients (Fluo-3 epifluorescence), fractional shortening, and SR Ca 2ϩ content of isolated VMs were assessed at 0.5 Hz, 35°C. 28 Thapsigargin (1 mol/L) was used to inhibit SR function and assess net Ca 2ϩ influx. Action potentials (APs), Ca 2ϩ currents, and Na ϩ / Ca 2ϩ exchange (NCX) currents were measured via a Axopatch 2B voltage-clamp amplifier as described previously. 11, 29 Immunostaining Isolated VMs were fixed, permeabilized, and stained to assess membrane localization of ␣1G, ␣1C, or RyR2.
Detubulation
Isolated VMs were incubated in a formamide solution (1.5 mol/L) for 15 minutes. Cells were quickly transferred to a formamide-free Tyrode's solution to induce detubulation.
An expanded Materials and Methods section can be found in the online data supplement at http://circres.ahajournals.org.
Results

Phenotype of Adult Mice With ␣1G-TTCC Overexpression
Previously 11 we showed that inducible, cardiac-specific overexpression of the ␤2a subunit of the LTCC increases Ca 2ϩ influx and myocyte contractility but eventually leads to depressed pump function, fibrosis, myocyte necrosis, cardiac hypertrophy, and premature death. 11 In the present study, we asked whether increases in Ca 2ϩ influx of a similar magnitude through TTCCs, a class of Ca 2ϩ channels reexpressed during cardiac disease, produced a similar excess Ca 2ϩ phenotype. Mice with cardiac-specific, inducible ␣1G expression were generated to define the functional role of these channels in the myocardium. A bitransgenic system was used in which a standard ␣-MHC promoter-driven expression of tTA (regu- Figure 2 . Ca 2ϩ influx in ␣1G and ␤2␣ myocytes. A, Representative I Ca,T (I Ca,L from Ϫ50 mV holding potential was subtracted from total Ca 2ϩ current recorded from Ϫ90 mV holding potential) in control and ␣1G VMs. B, Voltage-current relationship of I Ca,T (subtraction as in A) in control (nϭ10) and ␣1G (nϭ15) myocytes. C, Time course of I Ca,T recovery from inactivation (nϭ7) and representative example of I Ca,T recovery from inactivation (inset). D, Representative example of total Ca 2ϩ currents under AP voltage clamp in control, ␤2a, and ␣1G VMs at 0.5 Hz. E, Integral of total Ca 2ϩ current (without drugs) at different pacing frequencies in control (nϭ6), ␤2a (nϭ8), and ␣1G VMs (nϭ6). F, Representative example of [Ca 2ϩ ] i transients at baseline and after thapsigargin application (1 mol/L) at 1 mmol/L and 3 mmol/L bath Ca 2ϩ . G, Peak [Ca 2ϩ ] i transient and rise rate of the [Ca 2ϩ ] i transient after thapsigargin treatment (in 3 mmol/L Ca) in control (nϭ20), ␤2a (nϭ20), and ␣1G VMs (nϭ25). lated by doxycycline) is coupled to a modified ␣-MHC promoter containing the tet-operon for regulated expression of the ␣1G cDNA ( Figure 1A ). ␣1G mice, unlike the ␤2a mice, 11 had no premature death during the first 12 months of life. Similarly, there were no signs of histopathology ( Figure  1B ), cardiac dysfunction ( Figure 1C ), ventricular remodeling, or increases in myocyte death. For comparison, ␤2a hearts showed robust histopathology by 5 months of age ( Figure  1B ), as well as premature lethality. 11 Provocatively, not only were ␣1G mice without disease, they also showed enhanced ventricular performance (fractional shortening) compared with control animals ( Figure 1D ). These data show that expression of ␣1G-TTCCs induces a fundamentally different cardiac phenotype from overexpression of LTCC-␤2a subunit. 11
Ca 2؉ Influx via T-and LTCCs in ␣1G Mice
One possible explanation for the pathological phenotype of ␤2a versus ␣1G mice is that Ca 2ϩ influx is increased to a greater extent in ␤2a than ␣1G myocytes, resulting in Ca 2ϩ -mediated myocyte death. To address this possibility, we measured total Ca 2ϩ influx in myocytes from ␣1G and ␤2a myocytes. I Ca,T and I Ca,L were measured (Figures 2 and 3) using standard biophysical conditions. Control VMs had no I Ca,T , as expected, but I Ca,T was present in every ␣1G VM. Peak I Ca,T density ( Figure 2B ) was similar to peak I Ca,L density in the ␤2a mice ( Figure 3B ). The voltage dependence of I Ca,T was similar to published values observed in wild-type channels, with a peak near Ϫ30 mV ( Figure 2B ). I Ca,T also had normal recovery from inactivation, with 80% of TTCCs fully recov-ered within 100 ms ( Figure 2C ). Therefore, at the normal heart rates of ␣1G mice, TTCCs will be fully available for activation. I Ca,T was less sensitive to Ca 2ϩ than I Ca,L and was blocked by Ni 2ϩ (Figure 2D ), consistent with the known properties of wild-type ␣1G-TTCCs. These results show that the expressed ␣1G has functional and pharmacological properties like native I Ca,T .
AP voltage clamp was used to measure and compare the total Ca 2ϩ influx through both T-and LTCCs during a mouse AP ( Figure 2D ). Net Ca 2ϩ influx during an AP was similar in ␣1G and ␤2a VMs and 3-fold greater than in control VMs ( Figure 2E ). These studies show that the amount of excess Ca 2ϩ entry via TTCCs in ␣1G mice is approximately equal to the excess Ca 2ϩ entry via LTCCs in the ␤2a mice.
Differences in Ca 2ϩ influx in control, ␤2a, and ␣1G VMs were also compared by measuring the field-stimulated [Ca 2ϩ ] i transient after inhibition of SR function with thapsigargin (1 mol/L) ( Figure 2F and 2G). Peak [Ca 2ϩ ] i transients after thapsigargin treatment were similar in ␣1G and ␤2a VMs and significantly greater than control VMs. Peak rising rate of the [Ca 2ϩ ] i transient, which is an index of Ca 2ϩ flux, was also similar in ␣1G and ␤2a VMs and greater than control VMs. Collectively, these results show that Ca 2ϩ entry is increased to a similar extent in ␣1G and ␤2a mice. Therefore, differences in Ca 2ϩ influx magnitude do not explain the different phenotypes of ␣1G and ␤2a mice.
I Ca,L density was significantly smaller in ␣1G versus control myocytes ( Figure 3A through 3C) , and its voltage dependence of activation was shifted in the depolarized direction ( Figure 3D and 3E) . These changes may be a compensation (reduced Ca 2ϩ influx via the normal influx pathway) for the increased Ca 2ϩ influx through ␣1G-TTCCs.
AP, Contractions, and [Ca 2؉ ] i Transients in ␣1G Myocytes
We have previously shown that excess Ca 2ϩ influx through the LTCC increases myocyte contractions and [Ca 2ϩ ] i transients. 11 ␣1G VMs had longer AP durations at 50%, 70%, and 90% repolarization and a more prominent plateau phase than control VMs ( Figure 4A and 4B). Peak systolic [Ca 2ϩ ] i transients were greater in ␣1G versus control myocytes, and the rate of [Ca 2ϩ ] i transient decay was accelerated ( Figure 4C and 4D). Contraction magnitude of ␣1G myocytes was significantly greater than control myocytes. The duration of contraction was significantly shorter, and relengthening kinetics were accelerated in ␣1G versus control VMs ( Figure  4E and 4F). These results show that increases in Ca 2ϩ influx through ␣1G induces an increase in [Ca 2ϩ ] i transient and myocyte contraction but also suggest substantial changes in fundamental aspects of Ca 2ϩ handling in ␣1G myocytes. The increased [Ca 2ϩ ] i transient and contractility in ␣1G myocytes was significantly smaller than in ␤2a myocytes (Figure 4 ). 11 One possible explanation for these results is that increased Ca 2ϩ entry through TTCCs induces adaptations in myocyte Ca 2ϩ handling such as reducing Ca 2ϩ influx through the LTCCs (see above).
SR Calcium Load and I NCX
Our data suggest that excess Ca 2ϩ entry through TTCCs causes a much more modest increase in contractility than a similar increase in Ca 2ϩ entry through LTCCs. One possible explanation is that the 2 sources of Ca 2ϩ entry cause different degrees of SR Ca 2ϩ loading. To test this idea, we measured SR Ca 2ϩ content, defined as the caffeine-induced [Ca 2ϩ ] i transient. SR Ca 2ϩ content was not different in ␣1G versus control VMs ( Figure 5A and 5B), whereas SR Ca 2ϩ content was increased significantly in ␤2a myocytes ( Figure 5A and 5B). The decay phase of the caffeine-induced [Ca 2ϩ ] i transient primarily results from NCX-mediated Ca 2ϩ efflux and was not different between control and ␣1G VMs. I NCX measured at ϩ60 mV and Ϫ80 mV ( Figure 5C and 5D) was also similar in ␣1G and control myocytes. These results suggest that there are no significant changes in the density or [Ca 2ϩ ]-dependent activity of the NCX in ␣1G myocytes, unlike what we have observed in ␤2a myocytes. 11 These results suggest that increased Ca 2ϩ influx through T-and LTCCs are not equivalent in their respective abilities to load the SR.
Ca 2؉ Regulatory Proteins in ␣1G Hearts
The rate of decay of the systolic [Ca 2ϩ ] i transient and its duration were significantly shorter in ␣1G versus control VMs, suggesting significant alterations in myocyte Ca 2ϩ handling. To address this possibility, we measured Ca 2ϩ regulatory protein abundance and phosphorylation state in control and ␣1G hearts. Western blot analysis of ventricular tissue confirmed expression of ␣1G-TTCCs in ␣1G hearts and found no detectable ␣1G protein in control tissue ( Figure  6A ). ␣1G expression was associated with reduced ␣1C protein abundance, consistent with reduced I Ca,L amplitude (see Figure 3 ).
SERCA2a abundance was significantly greater, and phospholamban (PLB) abundance was reduced with increased phosphorylation of PLB-Ser16 and PLB-Thr17 in ␣1G versus control ventricles ( Figure 6A and 6B). These changes in SR protein abundance and phosphorylation can account for the enhanced rate of relaxation and more rapid decay of the [Ca 2ϩ ] i transient in ␣1G myocytes. No differences in RyR abundance or RyR-Ser2808 phosphorylation were observed in ␣1G hearts. NCX abundance was slightly but significantly greater in ␣1G versus control ventricles.
I Ca,T and EC Coupling
We next studied whether Ca 2ϩ influx through both T-and LTCCs were equally effective triggers of SR Ca 2ϩ release.
[Ca 2ϩ ] i transients and contractions induced by I Ca,L and I Ca,T in ␣1G VMs were measured in Na ϩ -and K ϩ -free conditions to eliminate Na ϩ and NCX currents and to minimize loss of voltage control. Voltage steps from Ϫ90 to Ϫ40 mV resulted in an I Ca,T with a 3-fold larger amplitude than the I Ca,L induced by voltage steps from Ϫ50 to ϩ10 mV (Figure 7 ). However, I Ca,T induced significantly smaller [Ca 2ϩ ] i transients than I Ca,L ( Figure 7C ), and these transients had a slower rate of rise than those induced by I Ca,L ( Figure 7F ). Contractions induced by I Ca,T were smaller than those induced by I Ca,L , and the kinetics of contractions were slower ( Figure 7D and 7G ). EC coupling gain (the ratio of peak [Ca 2ϩ ] i transient to peak Ca 2ϩ current) was nearly 3-fold smaller for I Ca,T versus I Ca,L ( Figure 7E ). Similar experiments in control VMs showed no I Ca,T , [Ca 2ϩ ] i transients, or contractions with voltage steps from Ϫ90 to Ϫ40 mV, whereas I Ca,L induced [Ca 2ϩ ] i transients and contractions from Ϫ50 to ϩ10 mV (data not shown). These findings show that Ca 2ϩ influx through ␣1G-TTCCs is not an effective trigger of SR Ca 2ϩ release, at least under our conditions.
TTCC Membrane Localization
One reason why ␣1G-TTCCs may be ineffective triggers of SR Ca 2ϩ release is that these channels are not localized to regions of the sarcolemma near the junctional SR. Localization of ␣1G on the VM membrane was determined using an ␣1G-specific antibody validated in previous studies. 12 This antibody labeled ␣1G-TTCCs that were primarily on the surface sarcolemma of VMs, with less staining within the T-tubules ( Figure 8A ). By comparison, the staining pattern of ␣1C, the pore-forming subunit of the LTCC, was primarily within the T-tubules, producing a similar pattern of coincident localization as RyR2 ( Figure 8C and 8D ). Membrane localization of T-and LTCCs was performed using confocal imaging at the level of the nucleus to ensure that similar intracellular and membrane surface regions were examined in every myocyte. This staining pattern supports the idea that I Ca,T is an ineffective trigger of SR Ca 2ϩ release because TTCCs are concentrated in the surface membrane away from the Ca 2ϩ release channels (RyR2).
Using antibodies to define membrane localization of ion channels can produce variable results. 31 Therefore, we used another independent technique to confirm that TTCCs are more concentrated in the surface membrane than in the T-tubules of ␣1G VMs. Formamide-induced osmotic shock produces rapid changes in cellular volume that causes T-tubules to detach from the surface membrane. 30 This detubulation technique has been used to confirm the principal localization of LTCCs within the T-tubule system. 30 We used this approach to examine the idea that TTCCs are not in high density within the T-tubules. Membrane staining with di-8-ANEPPS confirmed the presence and loss of T-tubules in normal and detubulated ␣1G VMs, respectively ( Figure 8E and 8F). Voltage-clamp techniques were then used to measure I Ca,L and I Ca,T in ␣1G VMs with and without detubulation ( Figure 8G ). Detubulation in ␣1G myocytes was associated with a 72% reduction in I Ca,L and a significantly smaller, 32% decline in I Ca,T , consistent with the antibody studies ( Figure  8H) . Collectively, these data support the idea that ␣1G-TTCCs are primarily on the surface membrane of VMs.
Discussion
The objective of this study was to define the functional role of TTCCs in adult VMs. TTCCs are expressed early in the developing heart, [12] [13] [14] where they are thought to contribute to pacemaking and the induction of contraction in immature myocytes. TTCC expression decreases after birth and few, if any, of these channels exist in adult VMs. 14 Cardiovascular diseases that increase systolic wall stress in the ventricle, such as hypertension and myocardial infarction, induce reexpression of TTCCs, [15] [16] [17] [18] [19] which was hypothesized to contribute to cardiac dysfunction, arrhythmias, and sudden death. 20 However, a direct link between Ca 2ϩ influx through TTCCs and these processes has not been causally established. To explore the role of TTCCs in the adult heart, we generated a mouse model with inducible expression of ␣1G-TTCCs.
␣1G mice had functional TTCCs that caused an increased Ca 2ϩ influx (Figure 2 ). Previously, we showed that increasing Ca 2ϩ influx through LTCCs by expressing its ␤2a subunit increases myocyte contractility but over time causes cardiac dysfunction by inducing myocyte death from SR Ca 2ϩ overload-induced necrosis. 11 These findings strongly support the idea that persistent increases in Ca 2ϩ influx eventually cause cardiomyopathy by reducing the number of functional cardiac myocytes, consistent with the known benefit of LTCC blockers in select forms of heart disease. 32 The ␣1G mice used in the present experiments had increases in Ca 2ϩ influx that were similar to or greater than in ␤2a mice, but, surprisingly, they did not develop a patholog-ical cardiac phenotype. These hearts and their resident myocytes were hypercontractile, but we could not detect evidence for cardiac histopathology or sudden death, at least during the first 12 months of life. These new studies show that increasing Ca 2ϩ influx through ␣1G-TTCCs, by itself, is not sufficient to induce cardiac dysfunction or arrhythmias. The reasons why increasing Ca 2ϩ influx through T-and LTCCs induces such fundamentally different phenotypes in the adult heart is not clear and will be a major topic for future studies. Our current studies suggest that the location of the Ca 2ϩ influx pathway appears to be the critical determinant of the induced cardiac phenotype.
Expression of ␣1G-TTCC Induces Alterations in Myocyte Ca 2؉ Handling
Ca 2ϩ influx was Ϸ3-fold greater than normal in both ␤2a and ␣1G VMs. In the absence of compensatory changes in other Ca 2ϩ regulatory processes, this increase in Ca 2ϩ entry should cause similar increases in myocyte contractility and SR Ca 2ϩ loading in myocytes from both transgenic mice. However, myocyte contractions and [Ca 2ϩ ] i transients were smaller in ␣1G versus ␤2a myocytes (Figure 4 and elsewhere 11 ). This appears to result from the fact that the SR Ca 2ϩ load was not increased in ␣1G VMs ( Figure 5 ), suggesting that T-and L-type Ca 2ϩ fluxes are handled differently by cardiac myocytes. In this regard, we observed a significant decrease in the duration of contraction and the [Ca 2ϩ ] i transient in ␣1G myocytes ( Figure 4C and 4E), suggesting that ␣1G-TTCC expression and the associated increase in Ca 2ϩ influx induced remodeling of other aspects of myocyte Ca 2ϩ handling. We explored these compensatory changes using cellular biophysical techniques and Western blot analysis.
Western blot analysis of ventricular tissue showed that the abundance and phosphorylation state of certain Ca 2ϩhandling proteins were altered in ␣1G hearts. The protein abundance of the LTCC-␣1C pore-forming subunit was significantly smaller in ␣1G versus control hearts. I Ca,L density was also smaller in ␣1G versus control VMs, consistent with the Western blot analysis. These results suggest that the increased Ca 2ϩ influx through the ␣1G-TTCCs induces a reduction in LTCC density. This compensatory change could reduce the likelihood of SR Ca 2ϩ overload and associated pathologies in ␣1G hearts. Western blot analysis also showed an increased SERCA2a expression level and a reduced PLN abundance with increased phosphorylation at PLB-Ser16 and PLN-Thr17 in ␣1G versus control hearts. These changes will promote Ca 2ϩ uptake by the SR and can explain the shortened [Ca 2ϩ ] i transient duration that we observed in ␣1G mice. Western blot analysis showed an increase in NCX abundance, but we did not find an increase in Ca 2ϩ -mediated NCX activity in ␣1G VMs in response to caffeine-induced SR Ca 2ϩ release.
Peak systolic Ca 2ϩ was increased in ␣1G versus control myocytes, but their SR Ca 2ϩ loads were not greater than in controls. We speculate that the increased systolic Ca 2ϩ in ␣1G myocytes results from an increase in Ca 2ϩ influx through TTCCs, together with a similar (to that in control VMs) Ca 2ϩ release from the SR (consistent with our finding that the SR Ca 2ϩ load is normal). Why an increase in ␣1G-mediated sarcolemmal Ca 2ϩ influx does not result in an increase in SR Ca 2ϩ loading is not clear, because increasing Ca 2ϩ influx via the LTCCs caused a significant increase in SR Ca 2ϩ loading ( Figure 5 ).
TTCCs Are on the Surface Sarcolemma, and LTCCs Are in T-Tubules
Our experiments demonstrate that Ca 2ϩ influx through T-and LTCCs have a different capacity to load the SR ( Figure 5 ) and to induce SR Ca 2ϩ release (Figure 7) . I Ca,T induced [Ca 2ϩ ] i transients with smaller amplitudes and slower rates of rise than those caused by I Ca,L , suggesting that TTCCs are not proximal to the RyRs to induce efficient SR Ca 2ϩ release. Our results also suggest that Ca 2ϩ entry via TTCCs is not taken up by the SR to the same extent as the Ca 2ϩ influx via LTCCs. We therefore went on to test the idea that T-and LTCCs are localized to different regions of the surface membrane.
Immunostaining showed that ␣1G-TTCCs are localized to the surface membrane and are not significantly localized within the T-tubules, the principal site of LTCC localization (Figure 8 ). The T-tubule system is composed of extensive invaginations of the cell membrane that allow rapid transmission of electric signals into the interior of the VM for spatial uniformity of SR Ca 2ϩ release for myocyte contraction. The fraction of cell membrane comprised by the T-tubular system is very species-dependent and has been reported to be between 50% and 64% for murine VMs. [33] [34] [35] [36] [37] LTCCs are localized to regions of the T-tubules ( Figure 8 ) that are in close apposition to the junctional SR. 30 To confirm that LTCCs are primarily within the T-tubule system and that TTCCs are primarily on the surface membrane, we used osmotic shock, which on the swelling phase of the protocol, causes T-tubules to separate from the surface membrane. Our imaging studies confirm that the primary membrane lost following osmotic shock is from the T-tubules and that this membrane contains more L-than TTCCs (Figure 8 ). We did not perform electrophysiological measurements in the same cells before and after osmotic shock, so we could not determine the percentage reduction in membrane capacitance in osmotically shocked myocytes. Collectively, our results show that Ca 2ϩ influx through T-and LTCCs has fundamentally different effects on EC coupling and SR Ca 2ϩ loading. We conclude that Ca 2ϩ entering VMs through T-and LTCCs occupies different submembrane compartments, where it has different effects on myocyte physiology.
Our findings in ␣1G VMs confirm previous reports that TTCCs are ineffective triggers of EC coupling. 23, 24 Indeed, Sipido et al demonstrated that TTCCs are much less efficient at triggering Ca 2ϩ release than LTCCs, and the authors attributed these differences to differential localization of Tand LTCCs. 23 We speculate that the differential membrane localization of T-and LTCCs in ␣1G VMs is responsible for the different phenotypes of ␤2a and ␣1G mice. The increased Ca 2ϩ entry through TTCCs at the surface membrane could be rapidly transported out of the cell, so that only a small fraction of this Ca 2ϩ enters the SR. This, coupled with a compensatory reduction in Ca 2ϩ entry through LTCCs, could explain the modest increase in contractility, with no significant change in SR Ca 2ϩ loading. Similar increases in total Ca 2ϩ entry through the LTCCs in ␤2a mice caused increased SR Ca 2ϩ loading, [Ca 2ϩ ] i transients, and contractility. Our most important finding is that increased Ca 2ϩ entry through TTCCs did not induce cardiac dysfunction, histopathology, or premature death. These results show that the Ca 2ϩ entry pathway, the location of the Ca 2ϩ channels within the membrane, as well as the Ca 2ϩ influx magnitude, determines the resultant cardiac phenotype. Additional studies are needed to determine the specific role of increased Ca 2ϩ influx via TTCCs under pathological conditions.
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